Clinical Trials

Adult Dermatology - Research

Dr. Tissa Hata and Dr. Richard Gallo currently have several ongoing clinical trials, including new biologic treatments for psoriasis, a sponsored trial on atopic dermatitis, and a National Institutues of Health funded study with Dr. Richard Gallo examining the role of probiotic treatments in atopic dermatitis patients.

Please contact ​Yun "Larry" Tong MD, Clinical Research Fellow at ​858-657-7192 or ​Faiza Shafiq MBBS, Clinical Research Associate at ​858-657-1697 if you would like more information about UC San Diego Dermatology clinical trials. Email: ​ucsddermstudies@gmail.com​​

UC San Diego Dermatology has several groups interested in the study of atopic dermatitis (AD), more commonly known as eczema. Our research interests include ongoing studies into basic immunologic defects present in patients with atopic dermatitis (Gallo Lab) and therapeutic trials at UC San Diego and Rady Children's Hospital.

Trials Now Recruiting Volunteers:UCSD-sponsored study investigating the effect seen on the skin microbiome after transplanting a probiotic cream made from commensal skin flora cultured from the subject’s own protective bacterial strains onto AD affected skin.

Trials Now Recruiting Volunteers:

       Vanda is sponsoring a study to investigate the safety and efficacy of 8 weeks of an oral medication with placebo for the itching that is associated with eczema. Patients having moderate to severe itching and ages between 18-65 may qualify. There are a total of 6 visits over a period of 8-12 weeks for a total compensation of $380.

PSORIASIS

UC San Diego Dermatology is fortunate to be supported by an endowment from the Charles and Anna Stern Foundation for research into psoriasis. Related projects include understanding the immune response of patients with psoriasis compared to atopic dermatitis and clinical trials ongoing at UC San Diego and Rady Children's Hospital.

Upcoming Adult Trials:

A 52 week clinical trial is sponsored by Novartis comparing secukinumab (Cosentyx) and ustekinumab (Stelara) in patients with moderate to severe psoriasis. Compensation will be provided. Patients 18 and above with moderate to severe psoriasis may qualify. 

ACTINIC KERATOSIS

Not currently recruiting

ROSACEA

Not currently recruiting

SKIN CANCER

UC San Diego Dermatology is in the process of expanding our research efforts in the study of cutaneous malignancies such as melanoma, basal cell carcinoma and squamous cell carcinomas. We are assisted in this endeavor by our relationship with the Moores UC San Diego Cancer Center. Our goals are to establish UC San Diego as a Skin Cancer Center of Excellence.  

Pediatric Dermatology Research

The Pediatric and Adolescent Dermatology Research Group is involved in clinical studies of common and uncommon diseases, including acne, fungal infections, eczema (atopic dermatitis), warts and molluscum and psoriasis. For more information, visit their website.

Pediatric & Adolescent Dermatology Research: 858-576-1700 x4295